$9.40
Price
$933M
Market Cap
—
P/E Ratio
-9.8
Forward P/E
$-2.21
EPS (TTM)
—
Dividend Yield
$201M
Cash
$96M
Total Debt
99M
Shares Out
$6.66
$18.90
52-Week Range
Institutional Ownership of ARS PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Third Point LLC|Daniel Loeb
|
1.0M | $8M | $9.90 | -5.25% |
Trading Activity for ARS PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q1 | |||||
| BUY | +79.8% | 1.0M | $8M | $9.41 | |
| 2025-Q4 | |||||
| BUY | NEW | 556.2K | $6M | $9.90 | |
Insider Trading for ARS PHARMACEUTICALS INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.